Moreover, cardiomyocyte-specific CatA overexpression reduced EC-SOD levels, resulting in oxidative stress, inflammation, ECM remodeling, and myocyte hypertrophy in vivo (58), whereas inhibition of CatA attenuated infarction-induced heart failure (60). The gene discussed is SOD1; the disease is heart failure.